- 10 Nov 2016 12:22
#14735353
One more about the way Big Pharm is making money. The sad thing is that medical workers often know about that or simply don't care...
Expensive new cancer drugs are contributing little to the life expectancy of dying patients, an expert has warned.
Despite billions of pounds of investment, most extend the lives of patients by a few months at best, according to analysis published in the British Medical Journal last night.
Dr Peter Wise, a retired consultant physician from Charing Cross Hospital in London, claims drug development has contributed little to the improvements in cancer life expectancy seen in recent decades.
The world’s biggest drug firms make huge sums from cancer drugs, with the most expensive treatments costing more than £100,000 a year.
Global sales hit £85billion last year, and that figure is set to soar with one in two people born today expected to get the disease at some point.
Already more than 352,000 are diagnosed each year in the UK - a number expected to hit 500,000 a year by 2035.
Billions are invested in new drugs, yet the 48 new cancer treatments approved between 2002 and 2014 only lengthened life expectancy by an average 2.1 months, Dr Wise said.
Source
Expensive new cancer drugs are contributing little to the life expectancy of dying patients, an expert has warned.
Despite billions of pounds of investment, most extend the lives of patients by a few months at best, according to analysis published in the British Medical Journal last night.
Dr Peter Wise, a retired consultant physician from Charing Cross Hospital in London, claims drug development has contributed little to the improvements in cancer life expectancy seen in recent decades.
The world’s biggest drug firms make huge sums from cancer drugs, with the most expensive treatments costing more than £100,000 a year.
Global sales hit £85billion last year, and that figure is set to soar with one in two people born today expected to get the disease at some point.
Already more than 352,000 are diagnosed each year in the UK - a number expected to hit 500,000 a year by 2035.
Billions are invested in new drugs, yet the 48 new cancer treatments approved between 2002 and 2014 only lengthened life expectancy by an average 2.1 months, Dr Wise said.
Source
- By Deutschmania
- By Tainari88
- By wat0n